Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the impact of sarcopenic obesity (SO) on weight loss outcomes and improvement of quality of life after laparoscopic sleeve gastrectomy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fujian Medical University
NCT07578103 · Body Composition Changes, Body Weight Change, and more
NCT07154719 · Musculoskeletal Abnormalities, Obesity, and more
NCT07484646 · Body Composition, Muscle Mass, and more
NCT07464899 · Diet Habits, Body Composition, and more
NCT06717659 · COPD (Chronic Obstructive Pulmonary Disease), Probiotic Intervention, and more
Chang-ming Huang
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions